BackgroundCheck.run
Search For

Maxwell Gordon, 79Bronx, NY

Known as:
Gordon J Maxwell Gordon C Maxwell Gordon Healy

Maxwell Gordon Phones & Addresses

Bronx, NY   

South Plainfield, NJ   

Orlando, FL   

Branchburg, NJ   

Clifton, NJ   

Work

Company: Eof summer program, new jersey institute of technology - Newark, NJ Jun 2013 Position: Physics and english tutor

Education

School / High School: New Jersey Institute of Technology- Newark, NJ Specialities: Civil Engineering
Get Report
Control this profile

Mentions for Maxwell Gordon

Maxwell Gordon resumes & CV records

Resumes

Maxwell Gordon Photo 20

Maxwell Gordon - Elizabeth, NJ

Work:
EOF Summer Program, New Jersey Institute of Technology - Newark, NJ Jun 2013 to Jun 2014
Physics and English Tutor EOF Summer Program, New Jersey Institute of Technology - Newark, NJ Sep 2013 to May 2014
Cataloging Assistant Sears - Woodbridge, NJ Mar 2011 to Apr 2012
Cashier
Education:
New Jersey Institute of Technology - Newark, NJ
Civil Engineering Rahway High School - Rahway, NJ Jun 2012

Publications & IP owners

Us Patents

Analgetic Dosage Forms That Are Resistant To Parenteral And Inhalation Dosing And Have Reduced Side Effects

US Patent:
2005016, Jul 28, 2005
Filed:
Jan 22, 2004
Appl. No.:
10/762714
Inventors:
Maxwell Gordon - New York NY, US
International Classification:
A61K031/485
A61K009/14
US Classification:
514282000, 424486000, 424488000
Abstract:
The invention provides a novel solid pharmaceutical dosage form which includes an opiate, an opiate antagonist admixed with the analgetic (opiate agonist) and an amount of a hydrocolloid containing excipient which is effective to form a non-injectable slurry when the dosage form is contacted with water. In addition the dosage form contains pure naloxone in enteric coated form which is designed to release in the colon to prevent or relieve constipation. Thus the formulation, because of the enteric coated naloxone and the hydrocolloid excipient(s), has reduced side effects as compared with formulations which do not contain these features.

Method Of Treating Acquired Immunedeficiency Syndrome

US Patent:
2006015, Jul 13, 2006
Filed:
Dec 8, 2005
Appl. No.:
11/298551
Inventors:
Maxwell Gordon - New York NY, US
Yutaro Kanoko - Bunkyo-ku, JP
International Classification:
A61K 31/737
US Classification:
514054000
Abstract:
HIV infections are treated with sequential treatment regimens comprising a first regimen which is a combination of highly active antiretroviral therapy drugs selected from the group consisting of nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors and protease inhibitors to reduce the HIV levels; and a second treatment regimen which is administered after said HIV levels are reduced or resistance is observed, said second treatment regimen an amount of an HIV entry/fusion inhibitor to form a modified treatment regimen and continuing to administer said modified treatment regimen for a period of from 10 to 30 days.

Analgetic Dosage Forms That Are Resistant To Parenteral And Inhalation Dosing And Have Reduced Side Effects

US Patent:
2011011, May 19, 2011
Filed:
Jan 18, 2011
Appl. No.:
12/930805
Inventors:
Maxwell Gordon - New York NY, US
International Classification:
A61K 9/00
A61K 31/485
A61P 25/04
A61P 1/12
US Classification:
424485, 424488, 514282
Abstract:
The invention provides a novel solid pharmaceutical dosage form which includes an opiate, an opiate antagonist admixed with the analgetic (opiate agonist) and an amount of a hydrocolloid containing excipient which is effective to form a non-injectable slurry when the dosage form is contacted with water. In addition the dosage form contains pure naloxone in enteric coated form which is designed to release in the colon to prevent or relieve constipation. Thus the formulation, because of the enteric coated naloxone and the hydrocolloid excipient(s), has reduced side effects as compared with formulations which do not contain these features.

Isbn (Books And Publications)

Psychopharmacological Agents

Author:
Maxwell Gordon
ISBN #:
0122905598

Conformationally Directed Drug Design: Peptides And Nucleic Acids As Templates Or Targets

Author:
Maxwell Gordon
ISBN #:
0841208360

Possible Relatives

Cynthia G Gordon  David Gordon  Dawn A Gordon  Dean O Gordon  Dale A Gordon  Debbie L Gordon  Deborah F Gordon  Maxwell C White  Maxwell P Jones  Maxwell M Mckay 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.